Entry Price Target Stop Loss Potential €45.8 €52.5 €42.4 +14.63%
As technical indicators suggest, PUMA SE’s share price may resume an upward trend in the medium term.
summary
● Overall, and from a short-term perspective, the company presents an interesting fundamental picture.
● According to Refinitiv, the company has a strong ESG score compared to its peers.
Strengths
●In terms of fundamentals, the enterprise value-to-sales ratio for this fiscal year is 0.82, which can be said to be at an undervalued level.
● Over the past four months, analysts’ average price targets have been revised upwards significantly.
Weaknesses
● Over the past 12 months, the trend in revenue revisions has been clearly trending downwards, highlighting downward revisions to analyst estimates.
● Analysts have significantly revised down their earnings estimates over the past year.
● Over the past 12 months, analyst consensus has been revised downwards significantly.
● The analysts covering the stock have widely differing price targets, suggesting difficulty in valuing the company and its business.
● Financial statements have disappointed market participants time and again, most of the time falling short of expectations.
© – 2024
The contents published here are general investment recommendations made by Surperformance, the publisher of MarketScreener.com, in accordance with regulations aimed at preventing market abuse. In particular, this recommendation is based on facts and expresses a good faith, complete and balanced opinion. This recommendation relies on internal or external data considered reliable as of the publication date. However, this information and the resulting recommendation may contain inaccuracies, errors or omissions, for which Surperformance assumes no responsibility. This recommendation does not constitute investment advice and is not suitable for all investor profiles. The reader acknowledges and accepts that investments in financial products involve risks, for which the reader bears full responsibility, without recourse to Surperformance. Surperformance undertakes to disclose all conflicts of interest that may affect the objectivity of the recommendation.
